ClinConnect ClinConnect Logo
Search / Trial NCT03591718

A Study to Test Different Doses of BI 456906 in Patients With Obesity

Launched by BOEHRINGER INGELHEIM · Jul 9, 2018

Trial Information

Current as of May 23, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male and female patients ≥ 18 years and \< 70 years of age at screening
  • Body Mass Index (BMI) ≥ 27 kg/m2 and \<40 kg/m2 at screening
  • A minimum absolute body weight of 70 kg at screening and a stable body weight (defined as no more than 5% change) 3 months prior to screening
  • HbA1c \<6.5%
  • Further inclusion criteria apply
  • Exclusion Criteria:
  • Women who are pregnant, nursing, or who plan to become pregnant while in the trial
  • Supine blood pressure (BP) ≥160/100 mmHg at screening
  • Major surgery (major according to the investigator's assessment) performed within 12 weeks prior to randomization or planned within 12 months after screening
  • Any laboratory value outside the reference range that the investigator considers to be of clinical relevance
  • Further exclusion criteria apply

About Boehringer Ingelheim

Boehringer Ingelheim is a global, research-driven pharmaceutical company dedicated to improving health and quality of life through innovative therapies. Established in 1885 and headquartered in Ingelheim, Germany, the company focuses on the development of prescription medicines in key therapeutic areas, including respiratory diseases, cardiovascular health, oncology, and immunology. Boehringer Ingelheim is committed to advancing medical science through rigorous clinical trials and collaborative research, striving to bring novel treatments to patients while upholding the highest standards of safety and efficacy. With a strong emphasis on sustainability and corporate responsibility, the company aims to make a meaningful impact on global health challenges.

Locations

Neuss, , Germany

Mainz, , Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials